UroGen Pharma Down over 14%, on Track for Largest Percent Decrease Since December 2025

Dow Jones11-04 23:45

UroGen Pharma Ltd. (URGN) is currently at $29.51, down $4.89 or 14.22%

--Would be lowest close since June 11, 2026, when it closed at $29.50

--On pace for largest percent decrease since Dec. 2, 2025, when it fell 14.34%

--Snaps a two day winning streak

--Up 26% year-to-date

--Down 54.83% from its all-time closing high of $65.33 on May 18, 2018

--Up 52.82% from 52 weeks ago (Nov. 5, 2025), when it closed at $19.31

--Down 41.32% from its 52-week closing high of $50.29 on Aug. 19, 2026

--Up 73.59% from its 52-week closing low of $17.00 on March 30, 2026

--Traded as low as $27.55; lowest intraday level since June 9, 2026, when it hit $26.60

--Down 19.91% at today's intraday low; largest intraday percent decrease since May 21, 2025, when it fell as much as 54.64%

All data as of 10:42:37 AM ET

Source: Dow Jones Market Data, FactSet

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment